Video

Dr. Petrylak: The Future of Prostate Cancer

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Image of Doctor.
Image of Dr. Tagawa.
Dr. Curtiland Deville Jr. discusses the importance of crafting an individualized treatment plan for patients with prostate cancer.
Image of a woman wearing a headband and glasses
Use of NeuroSAFE to guide nerve sparing during robot-assisted radical prostatectomy improved patient-reported erectile function.
Image of woman.
Image of Doctor.
Image of doctor with black hair.
Dr. Chandler Park, a medical oncologist of Genitourinary Medical Oncology, at the Norton Healthcare Institute, in Louisville, Kentucky.
Dr. Guru Sonpavde emphasized the importance of better understanding how genetic mutations influence the treatment of cancer care, particularly GU cancers.
Related Content
The addition of Erleada to ADT may provide less benefit in patients with metastatic castration-sensitive prostate cancer and fewer bone metastases: © stock.adobe.com.
May 14th 2025

Bone Metastasis Count May Guide Erleada Treatment in Prostate Cancer

Spencer Feldman
The addition of Erleada to ADT may provide less benefit in patients with metastatic castration-sensitive prostate cancer and fewer bone metastases.
cancer horizons podcast logo: a white microphone on a blue background
March 4th 2024

Cannabis Talks During Cancer, Cardiometabolic Comorbidities and Current Research

Alex Biese Brielle Benyon
In addition to a breakthrough therapy designation for a lung cancer drug, this week we’ll be talking a lot about additional side effects and health conditions that may come with a cancer diagnosis, and how to manage them.
New results from a breast cancer-related lymphedema study show the importance of measuring fluid and body composition before treatment begins: © H_Ko - stock.adobe.com.
May 2nd 2025

Pretreatment Baseline Screening for Breast Cancer-Related Lymphedema

Spencer Feldman
New results from a breast cancer-related lymphedema study show the importance of measuring fluid and body composition before treatment begins.
Guidelines for Childhood Neuroblastoma, FDA Decisions and More
February 12th 2024

Guidelines for Childhood Neuroblastoma, FDA Decisions and More

Alex Biese Brielle Benyon
Last week, we saw a few moving parts in the regulatory space, from new NCCN guidelines for pediatric neuroblastoma treatment to FDA Fast Tracks and Priority Reviews
Photo of a patient in consultation with a doctor.
April 25th 2025

Decipher Prostate Test Now Available for Metastatic Prostate Cancer

Spencer Feldman
Decipher Prostate Metastatic Genomic Classifier is now available for patients with metastatic prostate cancer.
The first patient has been enrolled in the ARID II trial for prostate cancer: stock.adobe.com.
April 24th 2025

First Patient Enrolled in ARID II Trial for Prostate Cancer Treatment

Spencer Feldman
The first patient has been enrolled in the ARID II trial evaluating Voro Urologic Scaffold to improve continence after prostate cancer surgery.